Everything here about bowel cancer risk and surveillance colonoscopy: our articles first, then short answers, the words you may hear, and the original sources.
Does Crohn's increase my risk of bowel cancer, and will I need regular colonoscopies?
It depends where your Crohn's is. Crohn's & Colitis UK says Crohn's affecting the colon raises bowel cancer risk, starting about eight years after symptoms begin, while Crohn's that does not affect the colon does not. Having PSC, a liver condition, raises it further. The overall risk is low. People at higher risk should be offered a surveillance colonoscopy, usually every 1 to 3 years. NICE and the British Society of Gastroenterology set out who needs one.
Do Crohn's medicines like azathioprine raise the risk of skin cancer?
Crohn's & Colitis UK says some immunosuppressants slightly increase the risk of some cancers, especially skin cancers, and the NHS lists sun sensitivity as a common side effect of azathioprine. To lower the risk, the charity advises staying in the shade from 11am to 3pm, using at least factor 30 sunscreen, covering up, wearing a hat and avoiding sunbeds. See a GP about any skin change that does not heal.
Cancer of the large bowel or rectum. Long-standing Crohn's of the colon raises the risk slightly, so some people are offered regular colonoscopy checks.
Cancer of the large bowel (colon) or back passage (rectum), also called bowel cancer. People whose Crohn's affects the colon have a somewhat higher risk.
A home poo test that looks for tiny amounts of hidden blood. It is mainly used to check for bowel cancer, while calprotectin is the better test for inflammation.
Common skin cancers such as basal cell and squamous cell carcinoma, often linked to sun exposure. The risk is slightly higher on some immunosuppressants such as thiopurines.
A long-term liver condition where the bile ducts become inflamed and scarred. In people with Crohn's or colitis it greatly raises the risk of bowel cancer.
A regular camera check of the large bowel to look for early changes that could turn into cancer, offered to people with Crohn's affecting the colon who are at higher risk.
Further reading 15
The original NHS, NICE, charity and research pages on this topic, with our summary of each.
Lists the main bowel cancer symptoms, several of which overlap with Crohn's: changes in poo, blood in poo that may look red or black, bleeding from the bottom, often feeling you need to poo, tummy pain, weight loss and tiredness from anaemia. Explains why these should be checked rather than assumed to be a flare.
Practical NHS advice on protecting skin from the sun: staying in the shade at the hottest times, covering up, and choosing and applying sunscreen properly. Useful for anyone on medicines that make skin more sun-sensitive.
Covers the common skin cancers that are not melanoma, such as basal cell and squamous cell carcinoma: what to look out for (a lump or patch that does not heal), when to see a GP, causes including sun exposure, and how to lower your risk. Relevant because some Crohn's medicines raise skin cancer risk slightly.
NHS medicine guide to azathioprine. It lists skin becoming more sensitive to sunlight as a common side effect, says it may not suit people recently given a live vaccine such as chickenpox or yellow fever, and says it can be used in pregnancy if a specialist recommends it, pointing to the Bumps website for more.
Explains what a colonoscopy is (a thin tube with a camera passed into the bowel), why you might be sent for one, including checking for Crohn's, and how to get ready. It describes taking laxatives beforehand to empty the bowel, what happens on the day and what to expect afterwards. It notes that most of the time the test does not find anything worrying.
Explains which people with Crohn's or Colitis have a raised risk of bowel and other gut cancers. Crohn's affecting the colon raises bowel cancer risk, starting about eight years after symptoms begin, and having PSC raises it further, while Crohn's that does not affect the colon does not. People at higher risk should be offered surveillance colonoscopy, usually every 1 to 3 years depending on risk. It also covers symptoms to watch for and ways to lower your risk.
Practical ways to lower the risks of medicines that suppress the immune system. You should not have live vaccines while on an immunosuppressant, but non-live vaccines such as the injected flu jab, COVID-19, Shingrix shingles and pneumococcal vaccines are safe. It explains checks for chickenpox immunity, the slightly raised risk of some cancers, especially skin cancer, and sun safety, plus food hygiene and travel precautions.
Alimentary Pharmacology & TherapeuticsDataMay 2020Patients and professionals
Using UK GP records from 2000 to 2017, this study found Crohn's became more common, rising from about 220 to 400 per 100,000 people. It predicted about 1 in 90 people in the UK would have IBD by 2025. Colitis was linked to a higher risk of bowel cancer, and both conditions to a somewhat higher risk of death than people without IBD.
British Society of GastroenterologyGuideline2025For professionals
The 2025 update of UK guidance on bowel cancer surveillance for people over 16 with IBD affecting the colon. It says people with IBD still have a higher risk of bowel cancer than the general population despite better treatment, and sets out who should and should not have surveillance, when to start and stop, and the importance of shared decision-making with patients.
NICE's guideline on which symptoms, including rectal bleeding, changes in bowel habit and iron deficiency anaemia, should lead to tests or urgent referral for possible cancer.
Gut (BMJ) via PubMed CentralGuidelineApr 2025For professionals
The 2025 UK guideline on regular colonoscopy checks for bowel cancer in adults with IBD affecting the colon, updating the 2010 version. It notes that people with IBD still have a higher bowel cancer risk than the general population and makes 73 statements on how a surveillance service should be run.
NICE's guideline on using regular colonoscopies to look for early signs of bowel cancer in adults with ulcerative colitis or Crohn's affecting the colon, and in people with polyps. Its aim is to find bowel cancer early in the people most at risk.
European Crohn's and Colitis Organisation (J Crohns Colitis)GuidelineJul 2025For professionals
A joint European guideline from gut doctors, radiologists, pathologists and bowel ultrasound experts on which tests to use to diagnose IBD, spot complications and keep track of it over time. It also covers testing in special situations such as pregnancy, after surgery and bowel cancer screening.
International Journal of Surgery Case ReportsCase reportJun 2022For professionals
A 71-year-old man with 22 years of Crohn's around his bottom developed a rare cancer inside a long-standing fistula. Because the symptoms (pain, a lump, bleeding) overlap with ordinary fistula problems, it is hard to spot. The authors advise doctors to consider biopsies and scans when long-standing perianal disease changes.
NICE's GP summary listing the complications of Crohn's: the effect on school, work and social life, narrowings, fistulas, disease around the bottom, perforation, heavy bleeding, anaemia, poor nutrition and slow growth in children, and a raised risk of bowel cancer when Crohn's affects the colon.